4//SEC Filing
Raser Jeffrey 4
Accession 0001209191-10-014268
CIK 0001339455other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:30 PM ET
Size
20.3 KB
Accession
0001209191-10-014268
Insider Transaction Report
Form 4
Raser Jeffrey
Senior VP, Sales and Marketing
Transactions
- Exercise/Conversion
Common Stock
2010-03-01−19,444→ 13,889 totalExercise: $1.23Exp: 2017-03-01→ Common Stock (19,444 underlying) - Exercise/Conversion
Common Stock
2010-03-01−5,446→ 77,887 totalExercise: $1.23Exp: 2019-02-16→ Common Stock (5,446 underlying) - Exercise/Conversion
Common Stock
2010-03-01$1.23/sh+19,444$23,916→ 43,554 total - Exercise/Conversion
Common Stock
2010-03-01−24,110→ 17,223 totalExercise: $1.23Exp: 2016-01-05→ Common Stock (24,110 underlying) - Exercise/Conversion
Common Stock
2010-03-01$1.23/sh+24,110$29,655→ 24,110 total - Exercise/Conversion
Common Stock
2010-03-01$1.23/sh+35,000$43,050→ 78,554 total - Exercise/Conversion
Common Stock
2010-03-01$1.23/sh+5,446$6,699→ 84,000 total - Sale
Common Stock
2010-03-01$4.08/sh−84,000$342,367→ 0 total - Exercise/Conversion
Common Stock
2010-03-01−35,000→ 25,000 totalExercise: $1.23Exp: 2018-02-18→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009.
- [F2]1/3 of the shares of Common Stock subject to this grant vested on the date of grant (June 9, 2009) and the remaining shares will vest and become exercisable in 24 equal monthly installments over the following two year period.
- [F3]Not applicable.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001346901
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:30 PM ET
- Size
- 20.3 KB